SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 39 filers reported holding SIO GENE THERAPIES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,656,000 | -22.3% | 5,914,000 | 0.0% | 0.07% | -14.8% |
| Q2 2022 | $2,130,000 | -46.2% | 5,914,000 | 0.0% | 0.08% | -33.1% |
| Q1 2022 | $3,962,000 | -48.1% | 5,914,000 | 0.0% | 0.12% | -18.2% |
| Q4 2021 | $7,629,000 | -35.9% | 5,914,000 | +7.7% | 0.15% | -26.4% |
| Q3 2021 | $11,911,000 | -20.5% | 5,489,000 | 0.0% | 0.20% | -10.3% |
| Q2 2021 | $14,985,000 | +4.6% | 5,489,000 | 0.0% | 0.22% | +5.7% |
| Q1 2021 | $14,326,000 | – | 5,489,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower View Wealth Management LLC | 11,645 | $1,348,000 | 1.02% |
| Cladis Investment Advisory, LLC | 552,000 | $155,000 | 0.20% |
| Rubric Capital Management LP | 7,000,000 | $1,960,000 | 0.10% |
| Newtyn Management, LLC | 1,500,000 | $420,000 | 0.09% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $1,656,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 146,500 | $41,000 | 0.06% |
| Clearline Capital LP | 392,691 | $110,000 | 0.01% |
| Hudson Bay Capital Management LP | 1,680,536 | $471,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 105,400 | $30,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 2,400 | $1,000 | 0.00% |